Direct Oral Anticoagulants for Very Elderly People With Atrial Fibrillation: Efficacy and Safe Enough?

about

Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation.

P2860

Q40624080-BF8A05AE-89D5-4AD5-9B81-2B8A5307152A

P2860

Direct Oral Anticoagulants for Very Elderly People With Atrial Fibrillation: Efficacy and Safe Enough?

Item

http://www.wikidata.org/entity/Q53652929

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Direct Oral Anticoagulants for ...... ion: Efficacy and Safe Enough?

@en

Direct Oral Anticoagulants for ...... ion: Efficacy and Safe Enough?

@nl

type

Item

label

Direct Oral Anticoagulants for ...... ion: Efficacy and Safe Enough?

@en

Direct Oral Anticoagulants for ...... ion: Efficacy and Safe Enough?

@nl

prefLabel

Direct Oral Anticoagulants for ...... ion: Efficacy and Safe Enough?

@en

Direct Oral Anticoagulants for ...... ion: Efficacy and Safe Enough?

@nl

P1476

Direct Oral Anticoagulants for ...... ion: Efficacy and Safe Enough?

@en

P2093

Antonella Bertone

http://www.w3.org/2001/XMLSchema#string

Giovanni Barillari

http://www.w3.org/2001/XMLSchema#string

Samantha Pasca

http://www.w3.org/2001/XMLSchema#string

Ugo Venturelli

http://www.w3.org/2001/XMLSchema#string

P2860

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness

Dabigatran versus warfarin in patients with atrial fibrillation

Epidemiology of atrial fibrillation: European perspective

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management.

Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.

EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.

P304

58-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029615619485

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26620417

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

atrial fibrillation

Direct Oral Anticoagulants for Very Elderly People With Atrial Fibrillation: Efficacy and Safe Enough?

about

P2860

P2860

Direct Oral Anticoagulants for Very Elderly People With Atrial Fibrillation: Efficacy and Safe Enough?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921